These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36870800)
1. Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma. Veziroglu EM; Farhadi F; Hasani N; Nikpanah M; Roschewski M; Summers RM; Saboury B Semin Nucl Med; 2023 May; 53(3):426-448. PubMed ID: 36870800 [TBL] [Abstract][Full Text] [Related]
8. FDG-PET/CT in the management of lymphomas: current status and future directions. El-Galaly TC; Villa D; Gormsen LC; Baech J; Lo A; Cheah CY J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234 [TBL] [Abstract][Full Text] [Related]
9. Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network. Blanc-Durand P; Jégou S; Kanoun S; Berriolo-Riedinger A; Bodet-Milin C; Kraeber-Bodéré F; Carlier T; Le Gouill S; Casasnovas RO; Meignan M; Itti E Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1362-1370. PubMed ID: 33097974 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update. Juweid ME; Mueller M; Alhouri A; A-Risheq MZ; Mottaghy FM Cancer; 2021 Oct; 127(20):3727-3741. PubMed ID: 34286864 [No Abstract] [Full Text] [Related]
11. Prognostic value of baseline Zhou Y; Hong Z; Zhou M; Sang S; Zhang B; Li J; Li Q; Wu Y; Deng S J Med Imaging Radiat Oncol; 2020 Feb; 64(1):87-95. PubMed ID: 31880103 [TBL] [Abstract][Full Text] [Related]
12. Pre-treatment total metabolic tumour volumes in lymphoma: Does quantity matter? El-Galaly TC; Villa D; Cheah CY; Gormsen LC Br J Haematol; 2022 Apr; 197(2):139-155. PubMed ID: 35037240 [TBL] [Abstract][Full Text] [Related]
13. Advanced artificial intelligence framework for T classification of TNM lung cancer in Trabelsi M; Romdhane H; Ben Salem L; Ben-Sellem D Biomed Phys Eng Express; 2024 Oct; 10(6):. PubMed ID: 39394688 [TBL] [Abstract][Full Text] [Related]
15. Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma. Cottereau AS; Hapdey S; Chartier L; Modzelewski R; Casasnovas O; Itti E; Tilly H; Vera P; Meignan MA; Becker S J Nucl Med; 2017 Feb; 58(2):276-281. PubMed ID: 27754905 [TBL] [Abstract][Full Text] [Related]
16. When should FDG-PET be used in the modern management of lymphoma? Barrington SF; Mikhaeel NG Br J Haematol; 2014 Feb; 164(3):315-28. PubMed ID: 24131306 [TBL] [Abstract][Full Text] [Related]
17. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Specht L Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566 [TBL] [Abstract][Full Text] [Related]
18. Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review. Dubreuil J; Salles G; Bozzetto J; Tordo J; Djaïleb L; Berriolo-Riedinger A; Leenhardt J; Giammarile F; Meignan M; Skanjeti A Nucl Med Commun; 2017 Jul; 38(7):563-576. PubMed ID: 28570287 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma. Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990 [TBL] [Abstract][Full Text] [Related]
20. Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments. Jemaa S; Paulson JN; Hutchings M; Kostakoglu L; Trotman J; Tracy S; de Crespigny A; Carano RAD; El-Galaly TC; Nielsen TG; Bengtsson T Cancer Imaging; 2022 Aug; 22(1):39. PubMed ID: 35962459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]